IN.PACT™ Admiral™ and IN.PACT™ 018 drug-coated balloons (DCB) Mechanism of Action
Mastering the future of PCI with drug-coated balloons - EuroPCR 2024
AGENT™ Drug Coated Balloon for Treatment of Coronary In stent Restenosis ISR
Drug Coated Balloon
The Role of Drug-Coated Balloons in Interventional Cardiology
Stellarex drug-coated angioplasty balloon product animation
Advances in the development of drug-coated balloon - EuroPCR 2025
AGENT™ Drug-Coated Balloon: Proven treatment for coronary in-stent restenosis (ISR)
Drug-coated balloons: a PREVAIL-ing gamechanger in complex PCI - AICT-AsiaPCR 2025
Transforming PCI: mastering the implementation of drug-eluting balloons - EuroPCR 2025
Treating patients with drug-coated balloons – what is the optimal result? - Webinar
When to use drug-coated balloons in de novo lesions? - EuroPCR 2023
From theory to practice: the versatility of drug-coated balloons around the world - EuroPCR 2025
TCT 2024 Case Study | AGENT Drug-Coated Balloon Presented by Dr. Jubin Joseph, MD, PhD
Treating PAD with IN.PACT Admiral Drug-Coated Balloon
INPACT Admiral Drug Coated Balloon
Drug-Coated Balloons and Their Role in CAD Management | Mishita Goel, MD
Drug coated balloon for angioplasty
Paclitaxel and sirolimus coated balloons: create evidence before claims - EuroPCR 2021
Drug Eluting Stent & Drug Coated Balloon | Concept Medical Products
